Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
暂无分享,去创建一个
Abidemi K. Adeniji | P. Vermersch | G. Comi | G. Giovannoni | S. Cook | P. Soelberg Sørensen | F. Dangond | K. Rammohan